CIK 0001885522 · Non-accelerated filer<br>Smaller reporting company
Neumora Therapeutics, Inc.
Sign in to watch- Ticker
- NMRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 844367680
- Phone
- (857) 760-0900
- Business address
- 260 ARSENAL PLACE, SUITE 1, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $481,506
- in 2 filings
Net −$481,506. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-19 | Burow Kristina Director | Conversion | +6,895,021 | 12,205,379 | ||
| 2023-09-19 | Burow Kristina Director | Conversion | +6,576,400 | 11,886,758 | ||
| 2023-09-19 | Burow Kristina Director | Conversion | +2,124,143 | 2,124,143 | ||
| 2023-09-19 | Burow Kristina Director | Purchase | +1,500,000 | $17.00 | $25.5M | 3,624,143 |
| 2023-09-19 | Burow Kristina Director | Conversion · Series A-1 Preferred Stock | −13,620 | 0 | ||
| 2023-09-19 | Burow Kristina Director | Conversion · Series A-1 Preferred Stock | −684,167 | 0 | ||
| 2023-09-19 | Burow Kristina Director | Conversion · Series A-1 Preferred Stock | −1,144,973 | 0 | ||
| 2023-09-19 | Burow Kristina Director | Conversion · Series A-2 Preferred Stock | −6,895,021 | 0 | ||
| 2023-09-19 | Burow Kristina Director | Conversion · Series A-2 Preferred Stock | −6,576,400 | 0 | ||
| 2023-09-19 | Burow Kristina Director | Conversion · Series B Preferred Stock | −2,124,143 | 0 | ||
| 2023-09-19 | ARCH Venture Partners X, LLC 10% owner | Conversion | +684,167 | 684,167 | ||
| 2023-09-19 | ARCH Venture Partners X, LLC 10% owner | Conversion | +1,144,973 | 1,144,973 | ||
| 2023-09-19 | ARCH Venture Partners X, LLC 10% owner | Conversion | +6,895,021 | 12,205,379 | ||
| 2023-09-19 | ARCH Venture Partners X, LLC 10% owner | Conversion | +6,576,400 | 11,886,758 | ||
| 2023-09-19 | ARCH Venture Partners X, LLC 10% owner | Conversion | +2,124,143 | 2,124,143 | ||
| 2023-09-19 | ARCH Venture Partners X, LLC 10% owner | Purchase | +1,500,000 | $17.00 | $25.5M | 3,624,143 |
| 2023-09-19 | ARCH Venture Partners X, LLC 10% owner | Conversion · Series A-1 Preferred Stock | −684,167 | 0 | ||
| 2023-09-19 | ARCH Venture Partners X, LLC 10% owner | Conversion · Series A-1 Preferred Stock | −1,144,973 | 0 | ||
| 2023-09-19 | ARCH Venture Partners X, LLC 10% owner | Conversion · Series A-2 Preferred Stock | −6,895,021 | 0 | ||
| 2023-09-19 | ARCH Venture Partners X, LLC 10% owner | Conversion · Series A-2 Preferred Stock | −6,576,400 | 0 |
Page 18 of 20 · 384 trades